Back
  1. Home
  2. Profile of Laetitia Montero-Ruiz (ULiège)
Profil

Montero-Ruiz Laetitia

GIGA Cancer - Tumors Biology and Development

Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire

See author's contact details
Main Referenced Co-authors
Sounni, Nor Eddine  (8)
Noël, Agnès  (7)
Jerusalem, Guy  (6)
Marangoni, Elisabetta (4)
Pottier, Charles  (4)
Main Referenced Keywords
Drug-resistance (1); EGFR (1); EGFR/MT4-MMP complex (1); Hypoxia (1); Lipid metabolism (1);
Main Referenced Unit & Research Centers
GIGA-LBTD - GIGA Cancer-Tumours and development biology - ULiège (1)
Main Referenced Disciplines
Oncology (7)
Biochemistry, biophysics & molecular biology (1)
Life sciences: Multidisciplinary, general & others (1)

Publications (total 8)

The most downloaded
288 downloads
Luis, G.* , Godfroid, A.* , Nishiumi, S., Cimino, J., Blacher, S., Maquoi, E., Wery, C., Collignon, A., Longuespée, R., MONTERORUIZ, L., Dassoul, I., Maloujahmoum, N., Pottier, C., Mazzucchelli, G., De Pauw, E., Bellahcene, A., Yoshida, M., Noël, A., & Sounni, N. E. (2021). Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biology, 43, 102006. doi:10.1016/j.redox.2021.102006 https://hdl.handle.net/2268/262273

The most cited

181 citations (OpenAlex)

Luis, G.* , Godfroid, A.* , Nishiumi, S., Cimino, J., Blacher, S., Maquoi, E., Wery, C., Collignon, A., Longuespée, R., MONTERORUIZ, L., Dassoul, I., Maloujahmoum, N., Pottier, C., Mazzucchelli, G., De Pauw, E., Bellahcene, A., Yoshida, M., Noël, A., & Sounni, N. E. (2021). Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biology, 43, 102006. doi:10.1016/j.redox.2021.102006 https://hdl.handle.net/2268/262273

Pottier, C., Montero-Ruiz, L., Jehay, R., Wery, C., Baiwir, D., Mazzucchelli, G., Bekisz, S., Thissen, R., Josse, C., Rorive, A., Gofflot, S., Dahmani, A., Morisset, L., Collignon, J., Delvenne, P., Marangoni, E., Noël, A., Jerusalem, G., & Sounni, N. E. (2025). Targeting ferroptosis resistance resensitizes metastatic HR+HER2- breast cancer cells to palbociclib-hormone therapy. Cancer Communications. doi:10.1002/cac2.12646
Peer Reviewed verified by ORBi

Pottier, C., Montero-Ruiz, L., Josse, C., Elisabetta Marangoni, Jerusalem, G., & Sounni, N. E. (03 February 2024). Ferroptosis as collateral sensitivity of ER+ HER2- breast cancer resistant to Palbociclib and Fulvestrant [Poster presentation]. 26th Annual Belgian Society of Medical Oncology meeting.

Farran, M., Montero-Ruiz, L., Sounni, N. E., & Noël, A. (2024). Suppressing metastasis by sensitizing cancer cells to ferroptosis in lymph nodes [Poster presentation]. 11th ISCaM Meeting, Brussels, Belgium.
Peer reviewed

Pottier, C., Montero-Ruiz, L., Noël, A., Jerusalem, G., & Sounni, N. E. (June 2022). Non genetic mechanisms of ER+ HER2- breast cancer resistance to the combination of Palbociclib and Fulvestrant [Poster presentation]. The European Association for Cancer Research Congress, Seville, Spain.
Editorial reviewed

Luis, G.* , Godfroid, A.* , Nishiumi, S., Cimino, J., Blacher, S., Maquoi, E., Wery, C., Collignon, A., Longuespée, R., MONTERORUIZ, L., Dassoul, I., Maloujahmoum, N., Pottier, C., Mazzucchelli, G., De Pauw, E., Bellahcene, A., Yoshida, M., Noël, A., & Sounni, N. E. (2021). Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biology, 43, 102006. doi:10.1016/j.redox.2021.102006
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

FOIDART, P., Yip, C., Radermacher, J., Blacher, S., Lienard, M., MONTERORUIZ, L., Maquoi, E., Montaudon, E., Chateau-Joubert, S., COLLIGNON, J., Coibion, M., Jossa, V., Marangoni, E., Noël, A., Sounni, N. E.* , & JERUSALEM, G.*. (2019). Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-18-1880
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

FOIDART, P., Yip, C., Radermacher, J., MONTERORUIZ, L., Coibion, M., Jossa, V., Marangoni, E., Noël, A., Sounni, N. E., & JERUSALEM, G. (24 February 2018). MT4-MMP, EGFR and RB expressions are predictive biomarkers of response to Erlotinib-Palbociclib combination in TNBC [Paper presentation]. Belgian Society of Medical Oncology: annual meeting, Ostende, Belgium.

FOIDART, P., Yip, C., Radermacher, J., MONTERORUIZ, L., Marangoni, E., Noël, A., Sounni, N. E., JERUSALEM, G., Coibion, M., Jossa, V., & BLACHER, S. (27 January 2018). Expression of MT4-MMP, EGFR and Rb in triple negative breast cancers strongly sensitizes tumors to Erlotinib and Palbociclib combination therapy [Paper presentation]. Belgian Association for Cancer Research : Annual Meeting, Liège, Belgium.

Contact ORBi